Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.

Journal of clinical pathology - 1 Sept 2018

Gong Qi-Xing, Wang Zhen, Liu Chong, Li Xiao, Lu Ting-Xun, Liang Jin-Hua, Xu Wei, Li Jian-Yong, Zhang Zhi-Hong

Abstract excerpt

AIM: CD30+ diffuse large B-cell lymphoma (DLBCL) has emerged as a new immunophenotypic variant of de novo DLBCLs. However, the prevalence of CD30 positivity is variable according to different studies, and the prognostic significance of CD30 is also controversial. This study aimed to investigate the positive expression rate and prognostic impact of CD30 in de novo DLBCLs and try to find the correlated influences....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Gene Rearrangement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Ki-1 Antigen

Share to Lymphoma, Large B-Cell, Diffuse

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins c-bcl-2

Share to Proto-Oncogene Proteins c-myc

Source

Identifiers

PMID: 29666157
DOI: 10.1136/jclinpath-2018-205039

Genes

BCL2
MYC
BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.PMID 29666157Read ↗

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomasSemantic proximity Read ↗

Genomic analysis reveals molecular characterization of CD30+ and CD30- extranodal natural killer/T-cell lymphomas (ENKTLs).Semantic proximity Read ↗

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.Semantic proximity Read ↗

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.Semantic proximity Read ↗

CD30 in Normal and Neoplastic CellsSemantic proximity Read ↗

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.Semantic proximity Read ↗

Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30)Semantic proximity Read ↗

Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.Semantic proximity Read ↗

Over‐expression of BACH 2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B ‐cell lymphomaSemantic proximity Read ↗

De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivity.Semantic proximity Read ↗

Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.Semantic proximity Read ↗

Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.